Independent Attestation Review: Health Resources and Services Administration Fiscal Year 2012 Performance Summary Report for National Drug Control Activities
Download the complete report
Adobe® Acrobat® is required to read PDF files.
We performed an attestation review of the Health Resources and Services Administration (HRSA) Performance Summary Report for National Drug Control Activities for fiscal year (FY) 2012.
As authorized by Federal statute (21 U.S.C. § 1703(d)(7)), and in compliance with the Office of National Drug Control Policy (ONDCP) Circular, Drug Control Accounting, dated May 1, 2007, ONDCP requested that we perform this review. Each National Drug Control Program agency must submit to the Director of ONDCP an annual evaluation of the progress by the agency with respect to drug control program goals using the performance measures established for that agency (21 U.S.C. § 1703(b)(13)). Section 9 of the circular allows an agency with prior-year drug-related obligations less than $50 million to submit an alternative report to ONDCP. Accordingly, ONDCP required that HRSA report on one performance measure. The Circular provides the requirements for the report.
Based on our review, nothing came to our attention that caused us to believe that HRSA's Performance Summary Report for National Drug Control Activities for FY 2012 was not fairly stated, in all material respects, based on the Circular.
Copies can also be obtained by contacting the Office of Public Affairs at Public.Affairs@oig.hhs.gov.
Let's start by choosing a topic
Priority recommendations summarized.
FY 2017 Work Plan
OIG projects planned for 2017.
Significant OIG activities in 6-month increments.